PriceTargets.com logo

Cigna Group - CI Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $334.45
  • Forecasted Upside: 24.81%
  • Number of Analysts: 24
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 19 Buy Ratings
  • 1 Strong Buy Ratings
$267.98 As of 12/4/2025 04:59 PM ET
▼ -2.34 (-0.87%)

This chart shows the closing price for CI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cigna Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CI

Analyst Price Target is $334.45
▲ +24.81% Upside Potential
This price target is based on 24 analysts offering 12 month price targets for Cigna Group in the last 3 months. The average price target is $334.45, with a high forecast of $384.00 and a low forecast of $270.00. The average price target represents a 24.81% upside from the last price of $267.98.

This chart shows the closing price for CI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 24 investment analysts is to moderate buy stock in Cigna Group. This rating has held steady since September 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 2 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 1 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 1 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 2 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 1 strong buy ratings
  • 16 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 2 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 1 strong buy ratings
  • 19 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
11/4/2025
  • 1 strong buy ratings
  • 19 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 1 strong buy ratings
  • 19 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/2/2025GuggenheimReiterated RatingBuy ➝ Buy$318.00
12/1/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
11/25/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
11/19/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
11/13/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
11/12/2025UBS GroupSet Target$294.00
11/12/2025Sanford C. BernsteinLower TargetMarket Perform ➝ Market Perform$346.00 ➝ $294.00
11/5/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$354.00 ➝ $300.00
11/4/2025CowenReiterated RatingBuy ➝ Buy
11/4/2025The Goldman Sachs GroupLower TargetBuy ➝ Buy$370.00 ➝ $330.00
11/4/2025TD CowenLower TargetBuy ➝ Buy$387.00 ➝ $333.00
11/4/2025JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$428.00 ➝ $375.00
11/3/2025Raymond James FinancialReiterated RatingStrong-Buy ➝ Strong-Buy
11/3/2025Jefferies Financial GroupReiterated RatingBuy ➝ Buy$310.00
11/3/2025Deutsche Bank AktiengesellschaftLower TargetBuy ➝ Buy$415.00 ➝ $301.00
11/3/2025Zacks ResearchDowngradeHold ➝ Strong Sell
10/31/2025Morgan StanleyReiterated RatingOverweight ➝ Overweight$355.00
10/31/2025BarclaysLower TargetOverweight ➝ Overweight$383.00 ➝ $300.00
10/31/2025Leerink PartnersLower Target$300.00 ➝ $270.00
10/31/2025Cantor FitzgeraldLower Target$365.00 ➝ $325.00
10/31/2025GuggenheimLower Target$350.00 ➝ $309.00
10/31/2025Truist FinancialLower Target$375.00 ➝ $310.00
10/15/2025Wolfe ResearchLower TargetOutperform ➝ Outperform$345.00 ➝ $325.00
10/14/2025The Goldman Sachs GroupInitiated CoverageBuy$370.00
10/14/2025The Goldman Sachs GroupInitiated CoverageBuy$370.00
10/8/2025Weiss RatingsReiterated RatingHold (C+) ➝ Hold (C+)
10/7/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$340.00 ➝ $354.00
9/27/2025Weiss RatingsReiterated RatingHold (C+) ➝ Hold (C+)
9/4/2025BarclaysBoost TargetOverweight ➝ Overweight$354.00 ➝ $383.00
9/2/2025Truist FinancialSet Target$375.00
8/26/2025Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$365.00
8/14/2025Robert W. BairdSet Target$372.00
8/14/2025Robert W. BairdBoost TargetOutperform ➝ Outperform$362.00 ➝ $374.00
8/14/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$341.00 ➝ $340.00
8/5/2025Deutsche Bank AktiengesellschaftSet TargetBuy ➝ Buy$415.00
8/4/2025GuggenheimReiterated RatingBuy ➝ Buy$388.00 ➝ $350.00
8/1/2025BarclaysLower TargetOverweight ➝ Overweight$385.00 ➝ $354.00
6/26/2025Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$371.00
6/23/2025TD CowenUpgradeStrong-Buy
6/3/2025Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$371.00
6/2/2025BarclaysReiterated RatingOverweight ➝ Overweight$382.00 ➝ $385.00
5/23/2025GuggenheimReiterated RatingBuy ➝ Buy$388.00
5/12/2025Truist FinancialBoost TargetBuy ➝ Buy$385.00 ➝ $405.00
5/5/2025CowenReiterated RatingBuy ➝ Buy
5/5/2025Piper SandlerBoost TargetOverweight ➝ Overweight$348.00 ➝ $374.00
5/5/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$379.00 ➝ $390.00
5/5/2025GuggenheimReiterated RatingBuy ➝ Buy$384.00 ➝ $388.00
5/5/2025BarclaysBoost TargetOverweight ➝ Overweight$339.00 ➝ $382.00
4/15/2025Robert W. BairdLower TargetOutperform ➝ Outperform$388.00 ➝ $362.00
4/11/2025Truist FinancialBoost TargetBuy ➝ Buy$375.00 ➝ $385.00
4/9/2025GuggenheimInitiated CoverageBuy$384.00
4/9/2025MizuhoBoost TargetOutperform ➝ Outperform$360.00 ➝ $384.00
3/20/2025Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$350.00 ➝ $365.00
2/6/2025Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$323.00
2/4/2025Truist FinancialLower TargetBuy ➝ Buy$390.00 ➝ $375.00
2/4/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$370.00 ➝ $341.00
2/3/2025UBS GroupLower TargetBuy ➝ Buy$410.00 ➝ $390.00
2/3/2025Piper SandlerReiterated RatingOverweight ➝ Overweight$394.00 ➝ $348.00
1/31/2025Royal Bank Of CanadaSet Target$355.00
1/31/2025Raymond James FinancialReiterated RatingStrong-Buy ➝ Strong-Buy$415.00 ➝ $360.00
1/31/2025OppenheimerLower TargetOutperform ➝ Outperform$400.00 ➝ $375.00
1/31/2025StephensLower TargetOverweight ➝ Overweight$410.00 ➝ $380.00
1/31/2025Cantor FitzgeraldLower TargetOverweight ➝ Overweight$400.00 ➝ $350.00
1/31/2025Morgan StanleyLower TargetOverweight ➝ Overweight$403.00 ➝ $379.00
1/31/2025BarclaysLower TargetOverweight ➝ Overweight$420.00 ➝ $339.00
1/6/2025Truist FinancialLower TargetBuy ➝ Buy$420.00 ➝ $390.00
11/5/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$392.00 ➝ $394.00
11/5/2024BarclaysBoost TargetOverweight ➝ Overweight$405.00 ➝ $420.00
11/4/2024Deutsche Bank AktiengesellschaftLower TargetBuy ➝ Buy$398.00 ➝ $394.00
11/1/2024StephensReiterated RatingOverweight ➝ Overweight$410.00 ➝ $410.00
11/1/2024Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$384.00 ➝ $377.00
10/23/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$400.00 ➝ $400.00
10/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$400.00 ➝ $400.00
9/17/2024Jefferies Financial GroupBoost TargetBuy ➝ Buy$402.00 ➝ $422.00
9/16/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$400.00 ➝ $400.00
9/10/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$400.00 ➝ $400.00
9/9/2024Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$384.00 ➝ $384.00
8/21/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$435.00 ➝ $438.00
8/19/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$400.00 ➝ $400.00
8/2/2024StephensReiterated RatingOverweight ➝ Overweight$410.00 ➝ $410.00
8/2/2024BarclaysBoost TargetOverweight ➝ Overweight$393.00 ➝ $405.00
7/10/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$400.00 ➝ $400.00
6/26/2024Piper SandlerInitiated CoverageOverweight$400.00
6/12/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$400.00 ➝ $400.00
5/30/2024Baird R WUpgradeStrong-Buy
5/30/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$432.00 ➝ $435.00
5/30/2024Robert W. BairdInitiated CoverageOutperform$388.00
5/3/2024Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$384.00 ➝ $400.00
5/3/2024OppenheimerBoost TargetOutperform ➝ Outperform$370.00 ➝ $400.00
4/10/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$384.00
3/6/2024BarclaysInitiated CoverageOverweight$393.00
3/4/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$372.00
3/4/2024Morgan StanleyReiterated RatingOverweight ➝ Overweight$382.00 ➝ $392.00
2/6/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$334.00 ➝ $348.00
2/5/2024MizuhoBoost TargetBuy ➝ Buy$360.00 ➝ $370.00
2/5/2024Cantor FitzgeraldUpgradeNeutral ➝ Overweight$334.00 ➝ $372.00
2/5/2024Royal Bank Of CanadaUpgradeSector Perform ➝ Outperform$327.00 ➝ $354.00
2/1/2024Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$355.00 ➝ $370.00
1/19/2024Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$334.00
1/17/2024OppenheimerReiterated RatingOutperform ➝ Outperform$360.00
1/4/2024Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$330.00 ➝ $372.00
12/12/2023Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$351.00 ➝ $355.00
12/11/2023Jefferies Financial GroupUpgradeHold ➝ Buy$335.00 ➝ $341.00
11/30/2023Royal Bank Of CanadaReiterated RatingSector Perform ➝ Sector Perform$327.00
11/15/2023Royal Bank Of CanadaReiterated RatingSector Perform ➝ Sector Perform$327.00
11/3/2023Royal Bank Of CanadaBoost TargetSector Perform ➝ Sector Perform$300.00 ➝ $327.00
11/3/2023Cantor FitzgeraldBoost TargetNeutral ➝ Neutral$310.00 ➝ $334.00
10/10/2023Sanford C. BernsteinBoost Target$326.00 ➝ $330.00
9/14/2023Cantor FitzgeraldBoost TargetNeutral ➝ Neutral$292.00 ➝ $310.00
8/17/2023Edward JonesDowngradeBuy ➝ Hold
8/9/2023Wells Fargo & CompanyBoost Target$284.00 ➝ $300.00
8/7/2023Raymond James FinancialBoost TargetStrong-Buy ➝ Strong-Buy$310.00 ➝ $330.00
8/4/2023Bank of AmericaBoost TargetBuy ➝ Buy$320.00 ➝ $350.00
7/7/2023JPMorgan Chase & Co.Lower Target$356.00 ➝ $341.00
6/20/2023Truist FinancialLower Target$375.00 ➝ $365.00
6/6/2023Bank of AmericaUpgradeNeutral ➝ Buy$320.00
5/30/2023JPMorgan Chase & Co.Lower Target$370.00 ➝ $356.00
5/8/2023Royal Bank Of CanadaLower Target$333.00 ➝ $287.00
5/8/2023Deutsche Bank AktiengesellschaftLower Target$348.00 ➝ $310.00
5/8/2023Raymond James FinancialLower Target$350.00 ➝ $310.00
5/8/2023Wells Fargo & CompanyLower Target$355.00 ➝ $284.00
4/26/2023Sanford C. BernsteinLower Target$367.00 ➝ $293.00
4/20/2023Cantor FitzgeraldInitiated CoverageNeutral$285.00
4/5/2023Raymond James FinancialUpgradeOutperform ➝ Strong-Buy$350.00
3/30/2023MizuhoReiterated RatingBuy$360.00
3/21/2023StephensReiterated RatingOverweight$370.00
2/28/2023StephensReiterated RatingOverweight$370.00
2/23/2023JPMorgan Chase & Co.Lower TargetOverweight$378.00 ➝ $370.00
2/8/2023Deutsche Bank AktiengesellschaftLower Target$359.00 ➝ $348.00
2/8/2023SVB SecuritiesLower Target$335.00 ➝ $309.00
2/8/2023Leerink PartnersBoost TargetMarket Perform$309.00 ➝ $335.00
2/7/2023Raymond James FinancialLower TargetOutperform$370.00 ➝ $350.00
2/6/2023Loop CapitalLower Target$350.00 ➝ $320.00
2/6/2023StephensLower TargetOverweight$385.00 ➝ $370.00
1/6/2023Morgan StanleyBoost TargetOverweight$347.00 ➝ $365.00
1/3/2023Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$370.00 ➝ $355.00
11/23/2022Morgan StanleyBoost TargetOverweight$318.00 ➝ $347.00
11/21/2022Raymond James FinancialDowngradeStrong-Buy ➝ Outperform$370.00
11/10/2022MizuhoBoost TargetBuy$330.00 ➝ $360.00
11/8/2022Wells Fargo & CompanyBoost Target$319.00 ➝ $370.00
11/8/2022Leerink PartnersBoost TargetMarket Perform$305.00 ➝ $335.00
11/7/2022Royal Bank Of CanadaBoost TargetSector Perform$294.00 ➝ $344.00
11/7/2022CowenBoost Target$329.00 ➝ $385.00
11/7/2022CowenBoost Target$329.00 ➝ $385.00
11/7/2022Credit Suisse GroupBoost TargetOutperform$329.00 ➝ $368.00
11/6/2022Raymond James FinancialBoost Target$330.00 ➝ $370.00
11/4/2022OppenheimerBoost Target$320.00 ➝ $360.00
8/17/2022Morgan StanleyBoost TargetOverweight$296.00 ➝ $318.00
8/10/2022Leerink PartnersBoost TargetMarket Perform$276.00 ➝ $305.00
8/9/2022The Goldman Sachs GroupBoost TargetNeutral$273.00 ➝ $311.00
8/8/2022Credit Suisse GroupBoost TargetOutperform$315.00 ➝ $329.00
8/8/2022UBS GroupBoost TargetBuy$310.00 ➝ $330.00
8/8/2022Wells Fargo & CompanyBoost TargetOverweight$306.00 ➝ $319.00
8/8/2022OppenheimerBoost TargetOutperform$310.00 ➝ $320.00
8/5/2022MizuhoBoost TargetBuy$291.00 ➝ $330.00
8/5/2022Royal Bank Of CanadaBoost Target$272.00 ➝ $294.00
7/19/2022Credit Suisse GroupSet Target$315.00
7/14/2022Jefferies Financial GroupReiterated RatingBuy ➝ Hold$330.00 ➝ $271.00
7/14/2022Truist FinancialBoost TargetBuy$310.00 ➝ $330.00
6/22/2022Morgan StanleyUpgradeEqual Weight ➝ Overweight$283.00 ➝ $296.00
6/16/2022Loop CapitalInitiated CoverageHold$270.00
6/9/2022Deutsche Bank AktiengesellschaftBoost Target$236.00 ➝ $284.00
6/7/2022OppenheimerReiterated RatingOutperform$310.00
5/27/2022Sanford C. BernsteinBoost TargetMkt Perform$258.00 ➝ $301.00
5/27/2022Morgan StanleyBoost TargetEqual Weight$235.00 ➝ $283.00
5/26/2022Sanford C. BernsteinInitiated CoverageMarket Perform$258.00 ➝ $301.00
5/26/2022Bank of AmericaUpgradeUnderperform ➝ Neutral$265.00 ➝ $300.00
5/23/2022BarclaysBoost TargetOverweight$275.00 ➝ $310.00
5/16/2022JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$248.00 ➝ $304.00
5/10/2022Raymond James FinancialBoost Target$275.00 ➝ $300.00
5/9/2022OppenheimerBoost TargetOutperform ➝ Outperform$300.00 ➝ $310.00
5/9/2022CowenUpgradeMarket Perform ➝ Outperform$242.00 ➝ $329.00
5/9/2022Truist FinancialBoost Target$290.00 ➝ $310.00
5/9/2022Royal Bank Of CanadaBoost Target$235.00 ➝ $272.00
5/9/2022MizuhoBoost Target$266.00 ➝ $291.00
5/9/2022Wells Fargo & CompanyBoost Target$278.00 ➝ $306.00
5/9/2022BMO Capital MarketsBoost Target$300.00 ➝ $320.00
5/9/2022CowenUpgradeMarket Perform ➝ Outperform$242.00 ➝ $329.00
4/20/2022StephensBoost TargetOverweight$265.00 ➝ $290.00
4/7/2022Truist FinancialBoost Target$275.00 ➝ $290.00
3/2/2022MizuhoBoost TargetBuy$245.00 ➝ $266.00
2/22/2022Leerink PartnersBoost TargetMarket Perform$224.00 ➝ $245.00
2/10/2022Morgan StanleyLower TargetEqual Weight$238.00 ➝ $235.00
2/7/2022Royal Bank Of CanadaDowngradeOutperform ➝ Sector Perform$304.00 ➝ $235.00
2/4/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$271.00 ➝ $236.00
1/11/2022Sanford C. BernsteinBoost Target$234.00 ➝ $258.00
1/6/2022Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$236.00 ➝ $278.00
1/5/2022Truist FinancialBoost Target$270.00 ➝ $275.00
12/21/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$270.00 ➝ $248.00
12/20/2021MizuhoLower TargetBuy$267.00 ➝ $245.00
12/16/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$255.00 ➝ $238.00
12/14/2021The Goldman Sachs GroupInitiated CoverageNeutral$233.00
11/17/2021Seaport Res PtnReiterated RatingBuy
11/12/2021Morgan StanleyLower TargetOverweight$275.00 ➝ $255.00
11/8/2021BMO Capital MarketsLower TargetOutperform$300.00 ➝ $275.00
11/8/2021Credit Suisse GroupBoost TargetOutperform$270.00 ➝ $300.00
11/5/2021Leerink PartnersReiterated RatingHold$223.00
11/5/2021Jefferies Financial GroupBoost TargetBuy$270.00 ➝ $277.00
10/11/2021UBS GroupLower TargetBuy$285.00 ➝ $244.00
9/27/2021Leerink PartnersInitiated CoverageMarket Perform$220.00
9/10/2021Bank of AmericaDowngradeBuy ➝ Underperform$240.00 ➝ $225.00
9/9/2021CowenInitiated CoverageMarket Perform$235.00
8/31/2021Morgan StanleyLower TargetOverweight$321.00 ➝ $275.00
8/9/2021Raymond James FinancialLower TargetStrong-Buy$317.00 ➝ $275.00
8/6/2021Truist FinancialLower TargetBuy$320.00 ➝ $270.00
8/6/2021Credit Suisse GroupLower TargetOutperform$300.00 ➝ $270.00
8/6/2021Bank of AmericaLower TargetBuy$300.00 ➝ $240.00
8/6/2021Deutsche Bank AktiengesellschaftLower TargetBuy$270.00 ➝ $266.00
8/6/2021Jefferies Financial GroupLower TargetBuy$304.00 ➝ $270.00
8/6/2021OppenheimerLower TargetOutperform$300.00 ➝ $285.00
8/6/2021BMO Capital MarketsLower TargetOutperform$315.00 ➝ $300.00
8/6/2021StephensLower TargetOverweight$300.00 ➝ $270.00
8/6/2021MizuhoLower TargetBuy$290.00 ➝ $267.00
8/6/2021CitigroupLower TargetBuy$308.00 ➝ $267.00
7/13/2021Deutsche Bank AktiengesellschaftSet TargetBuy$235.22
6/3/2021Morgan StanleyBoost TargetOverweight$254.00 ➝ $321.00
5/24/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$284.00
5/18/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$284.00
5/14/2021Royal Bank Of CanadaBoost TargetOutperform$265.00 ➝ $304.00
5/10/2021Truist FinancialBoost Target$300.00 ➝ $320.00
5/10/2021Credit Suisse GroupBoost TargetOutperform$270.00 ➝ $300.00
5/10/2021BMO Capital MarketsBoost TargetOutperform$300.00 ➝ $315.00
5/10/2021MizuhoBoost TargetBuy$264.00 ➝ $290.00
4/14/2021Truist FinancialBoost Target$280.00 ➝ $300.00
3/9/2021Truist FinancialBoost Target$260.00 ➝ $280.00
3/9/2021BMO Capital MarketsBoost TargetOutperform$270.00 ➝ $290.00
3/9/2021MizuhoBoost TargetPositive ➝ Buy$229.00 ➝ $264.00
2/8/2021Morgan StanleyLower TargetOverweight$258.00 ➝ $254.00
2/5/2021CitigroupReiterated RatingBuy$273.00
2/5/2021Deutsche Bank AktiengesellschaftLower TargetBuy$280.00 ➝ $270.00
12/18/2020MizuhoBoost TargetBuy$220.00 ➝ $229.00
12/14/2020Leerink PartnersBoost TargetMarket Perform$230.00 ➝ $240.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.39 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 3 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
9/5/2025
  • 93 very positive mentions
  • 22 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 100 very positive mentions
  • 47 positive mentions
  • 8 negative mentions
  • 2 very negative mentions
Mentions as of
11/4/2025
  • 124 very positive mentions
  • 27 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 124 very positive mentions
  • 27 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Cigna Group logo
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Read More

Today's Range

Now: $267.98
Low: $266.51
High: $272.09

50 Day Range

MA: $283.63
Low: $244.67
High: $311.24

52 Week Range

Now: $267.98
Low: $239.51
High: $350.00

Volume

1,551,411 shs

Average Volume

2,008,736 shs

Market Capitalization

$71.59 billion

P/E Ratio

11.82

Dividend Yield

2.23%

Beta

0.26

Frequently Asked Questions

What sell-side analysts currently cover shares of Cigna Group?

The following Wall Street research analysts have issued reports on Cigna Group in the last year: Barclays PLC, Cantor Fitzgerald, Cowen Inc, Deutsche Bank Aktiengesellschaft, Guggenheim, Jefferies Financial Group Inc., JPMorgan Chase & Co., Leerink Partners, Mizuho, Morgan Stanley, Oppenheimer Holdings, Inc., Piper Sandler, Raymond James Financial, Inc., Robert W. Baird, Royal Bank Of Canada, Sanford C. Bernstein, Stephens, TD Cowen, The Goldman Sachs Group, Inc., Truist Financial Corporation, UBS Group AG, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, Wolfe Research, and Zacks Research.
View the latest analyst ratings for CI.

What is the current price target for Cigna Group?

0 Wall Street analysts have set twelve-month price targets for Cigna Group in the last year. Their average twelve-month price target is $334.45, suggesting a possible upside of 24.8%. Mizuho has the highest price target set, predicting CI will reach $384.00 in the next twelve months. Leerink Partners has the lowest price target set, forecasting a price of $270.00 for Cigna Group in the next year.
View the latest price targets for CI.

What is the current consensus analyst rating for Cigna Group?

Cigna Group currently has 1 sell rating, 3 hold ratings, 19 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CI.

What other companies compete with Cigna Group?

Other companies that are similar to Cigna Group include Centene, Elevance Health, HCA Healthcare, Humana and UnitedHealth Group. Learn More about companies similar to Cigna Group.

How do I contact Cigna Group's investor relations team?

Cigna Group's physical mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The health services provider's listed phone number is (860) 226-6000 and its investor relations email address is [email protected]. The official website for Cigna Group is www.cigna.com. Learn More about contacing Cigna Group investor relations.